Cold Therapy and the Immune System: What the Research Actually Shows (2026)
Ask a cold therapy advocate whether ice baths boost immunity and you'll hear a confident yes. Ask a clinical immunologist and you'll hear considerably more nuance. The honest answer is that the relationship between cold water immersion and immune function is genuinely interesting — and the evidence for certain effects is real — but it is more carefully bounded than the wellness industry typically presents it. This article covers what the research actually shows, what it doesn't, and how to think about immune function as part of a broader cold therapy practice.
The Sick Day Study: The Strongest Evidence We Have
The most rigorous human study on cold therapy and immune outcomes is Buijze et al. (PLOS ONE, 2016). In a randomised controlled trial involving over 3,000 participants, those assigned to end their showers with 30–90 seconds of cold water experienced 29% fewer sick days compared to the control group who showered normally. This is a meaningful, peer-reviewed finding — a prospective trial with a large sample, properly controlled, showing a real effect on sick leave.
Buijze et al. (PLOS ONE, 2016): over 3,000 participants in a randomised controlled trial. Those who ended their showers with 30–90 seconds of cold water took 29% fewer sick days. The cold group did not get sick less often — they recovered faster and returned to work sooner.
The critical detail is in the mechanism. The cold shower group did not report falling ill less frequently than the control group. They recovered more quickly from illness when it occurred — resulting in fewer workdays lost. This distinction matters. Cold therapy does not appear to prevent infection. It appears to modulate the body's response to illness, potentially accelerating recovery time. These are different claims, and the difference is meaningful when evaluating what cold therapy can and cannot realistically do for your health.
The Neurochemical–Immune Link
The mechanism most consistent with the evidence connects cold therapy's neurochemical response to immune function via the sympathetic nervous system. Cold water immersion produces a significant elevation in norepinephrine — research documents a 200–300% rise per session, sustained for hours. Norepinephrine is not only a neurotransmitter affecting focus and mood; it is also a direct modulator of immune function. Immune cells express adrenergic receptors — the molecular docking sites for norepinephrine — and their activity responds to catecholamine levels in the circulation.
This pathway, often termed the sympatho-immunological axis, explains how a physiological stressor like cold immersion can have downstream effects on immune cell behaviour. Natural killer cell activity and lymphocyte mobilisation are both influenced by norepinephrine levels. Elevated catecholamines following cold exposure are associated with short-term increases in circulating immune cell counts. The implication is not that cold therapy turns on the immune system — it is that it activates mechanisms that are also involved in immune regulation, with measurable short-term effects on immune cell distribution and behaviour.
Hormesis: The Stress Adaptation Model
The hormesis framework is the most compelling broader model for understanding how regular cold exposure might support resilience, including immune resilience. Hormesis describes the biological principle that brief, controlled stressors trigger adaptive responses that strengthen the organism's capacity to handle future challenges. Cold immersion is a well-characterised hormetic stressor: on entry, it activates the sympathoadrenal axis — elevated catecholamines, increased heart rate, accelerated metabolic rate. With repeated exposure, the acute alarm response habituates and the adaptive response becomes more efficient.
The immune dimension of this is that the sympatho-immunological axis activation from repeated cold sessions may contribute to a more robustly regulated immune response over time — one that activates appropriately and resolves efficiently. This is consistent with the sick day finding in Buijze et al.: not fewer infections, but faster resolution of illness when it occurs. Whether this effect is primarily hormetic — driven by the adaptive response to repeated cold stress — or primarily acute, driven by the catecholamine elevation per session, remains an open question in the literature.
What the Evidence Does Not Claim
It is important to be explicit about the limits of the evidence. Cold therapy has not been shown to prevent respiratory infections, reduce cancer risk, or substitute for evidence-based immunological interventions such as vaccination. The mechanistic evidence on natural killer cell mobilisation and lymphocyte response is largely from small studies with limited follow-up. The Buijze (2016) study is the strongest human trial available — and it showed a sick day reduction, not an infection prevention effect. Claims that cold therapy prevents illness or categorically "boosts" the immune system go beyond what the peer-reviewed evidence currently supports.
Cold therapy is not a substitute for sleep, nutrition, vaccination, or medical care. The evidence supports faster recovery from illness as a plausible effect. It does not support preventing infection or replacing evidence-based healthcare.
Cold Therapy and Overtraining: The Important Caveat
For athletes, there is a relevant caution: extreme cold exposure, like extreme training load, is a physiological stress. In heavy training blocks where immune suppression from overtraining is already a concern, cold therapy should be used as a recovery tool — appropriately timed, at the right temperature, for 3–5 minutes — not escalated as an additional stressor on top of already high systemic load. The hormetic benefit of cold therapy exists at controlled doses. Excessive duration or frequency combined with under-recovery from training is not a hormetic stimulus — it is an accumulating stressor that can worsen the immune suppression it was meant to counteract.
Evidence Summary: What Is and Is Not Supported
Practical Guidance: Building an Immune-Aware Cold Practice
- →Maintain frequency — hormetic adaptation and any immune-regulatory benefit require consistent practice; fewer than three sessions per week limits cumulative effect
- →Prioritise morning sessions — cold therapy in the morning aligns the catecholamine elevation with the waking period and avoids the sleep disruption that would undermine immune resilience from the opposite direction
- →Do not escalate cold therapy when already under-recovered — stacking cold sessions on top of high training load and poor sleep is counterproductive, not additive
- →Treat cold therapy as part of a complete recovery approach — sleep, nutrition, and training load management are the primary levers of immune health; cold therapy is a supporting tool, not the foundation
- →During high-risk periods (winter training camps, congested fixtures, high training stress), three to five sessions per week at 8–12°C is a practical immune-supportive protocol for athletes
The UK Consistency Problem
For immune support specifically, consistent moderate cold exposure is more likely to produce adaptive effects than infrequent extreme exposure. The hormetic model requires repeated, recoverable stressor events across weeks and months. Three sessions per week at 10°C, sustained year-round, is more likely to produce cumulative regulatory benefit than a protocol that works from October to April and degrades over summer. In the UK, mains water reaches 15–18°C by July — above the meaningful stimulus threshold for anyone with established cold adaptation. A practice designed to support immune resilience year-round requires a cold water source that does not vary with the season. The VP-1 Pro's 770W compressor holds 10°C in August as reliably as in January — the same controlled stimulus, the same protocol, every week of the year.
The Bottom Line
Cold therapy's relationship with immune function is real and mechanistically coherent — but more carefully bounded than the wellness conversation typically admits. The strongest evidence is a 29% reduction in sick days from a large RCT (Buijze et al., PLOS ONE 2016), driven by faster illness recovery rather than infection prevention. The mechanism runs through the sympatho-immunological axis — the same catecholamine response that drives focus and mood also influences immune cell activity. Regular cold practice, used as part of a complete recovery approach at a consistent temperature year-round, is a reasonable tool for supporting immune resilience across a demanding training year. It is not a substitute for sleep, nutrition, or medical care. But the evidence for the claims it can legitimately make is solid — and that is more than most wellness practices can say.
Consistent cold therapy — any season, any month
The VP-1 Pro holds 10°C in July as reliably as January. 770W compressor, 4-stage filtration with UV-C sterilisation, 18-month warranty. 25 units at £899 Founders pricing.
Secure your VP-1 Pro →MyoChill vs VP-1 Pro: The Honest UK Ice Bath Comparison (2026)
Two of the most-searched UK ice bath chillers compared side by side. Power, filtration, price — and which one actually makes sense for serious athletes.
Read →Best Ice Bath Chillers UK 2026: Complete Buyer's Guide
A no-nonsense guide to the UK ice bath chiller market — what specs actually matter, what to avoid, and which system offers the best value for serious athletes.
Read →